| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net income | ||||||
193,157 | 173,024 | 145,053 | 0 | 0 | 0 | |
Adjustments to reconcile net income to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
143,003 | 139,330 | 135,948 | 0 | 0 | 0 | |
Stock-based compensation expense | ||||||
53,121 | 49,824 | 0 | 0 | 0 | - | |
Deferred taxes | ||||||
22,290 | 15,024 | -8,050 | 0 | 0 | 0 | |
(Increase) decrease in operating assets: | ||||||
Receivable from/payable to brokers and dealers and clearing organizations, net | ||||||
33,544 | -3,188 | 571,804 | 0 | 0 | 0 | |
Deposits with clearing organizations | ||||||
2,449 | -1,789 | 2,927 | 0 | 0 | 0 | |
Accounts receivable | ||||||
41,330 | 4,283 | 1,336 | 0 | 0 | 0 | |
Receivable from/payable to affiliates, net | ||||||
1,176 | 2,461 | 1,373 | 0 | 0 | 0 | |
Other assets | ||||||
8,333 | 5,648 | 12,936 | 0 | 0 | 0 | |
Increase (decrease) in operating liabilities: | ||||||
Accrued compensation | ||||||
4,754 | -1,783 | 13,226 | 0 | 0 | 0 | |
Deferred revenue | ||||||
-2,201 | -3,905 | 286 | 0 | 0 | 0 | |
Accounts payable, accrued expenses and other liabilities | ||||||
15,428 | -3,550 | 7,248 | 0 | 0 | 0 | |
Employee equity compensation payable | ||||||
738 | -16,412 | -7,401 | 0 | 0 | 0 | |
Net cash used in operating activities | ||||||
310,324 | 311,003 | 303,021 | 0 | 0 | 0 | |
Cash flows from investing activities | ||||||
Purchase of furniture, equipment, software and leasehold improvements | ||||||
15,563 | 15,781 | 17,657 | 0 | 0 | 0 | |
Capitalized software development costs | ||||||
28,977 | 28,681 | 28,356 | 0 | 0 | 0 | |
Net cash used in investing activities | ||||||
-44,540 | -44,462 | -46,013 | 0 | 0 | 0 | |
Cash flows from financing activities | ||||||
Pre-IPO capital distributions | ||||||
- | - | - | - | - | 0 | |
Proceeds from stock-based compensation exercises | ||||||
0 | - | - | - | - | - | |
Offering costs from follow-on offering | ||||||
0 | - | - | - | - | - | |
Dividends | ||||||
0 | - | - | - | - | - | |
Capital distributions to non-controlling interests | ||||||
- | 38,346 | 0 | 0 | 0 | - | |
Payroll taxes paid for stock-based compensation exercises | ||||||
0 | - | - | - | - | - | |
Net cash used in financing activities | ||||||
-200,419 | -218,142 | -214,856 | 0 | 0 | 0 | |
Effect of exchange rate changes on cash and cash equivalents | ||||||
-2,816 | 2,008 | -2,405 | 0 | 0 | 0 | |
Net decrease in cash and cash equivalents | ||||||
62,549 | 50,407 | 39,747 | 0 | 0 | 0 | |
Supplemental disclosure of cash flow information | ||||||
Income taxes paid | ||||||
39,408 | 43,842 | 32,946 | 0 | 0 | 0 | |
Non-cash financing activities - Items arising from LLC Interest ownership changes | ||||||
Deferred tax asset | ||||||
0 | - | - | - | 0 | 0 | |
Conversion of certain cash-settled PRSUs to equity-settled PRSUs | ||||||
- | - | - | - | - | 0 | |
Refinitiv Transaction | ||||||
Deferred taxes | ||||||
0 | - | - | - | - | - | |
Establishment of liabilities under tax receivable agreement | ||||||
0 | - | - | - | - | - | |
Deferred tax asset | ||||||
0 | - | - | - | - | - | |